Atai Life Sciences ATAI Q1 2026 earnings
Reported May 12, 2026 · Before market open
Revenue$954.0KBeat by $736.9K
EPS-$0.08Beat by $0.03
Revenue estimate$217.1K
EPS estimate-$0.11
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$111.1K
EPS estimate-$0.10
Versus estimates
Revenue
Q1 2026$954.0KBeat by $736.9K
Q4 2025$1.1MBeat by $766.0KQ3 2025$749.0KBeat by $519.8KQ2 2025$719.0KQ1 2025$1.6MQ4 2024-$5.0KMiss by $305.0KDiluted EPS
Ask the moment Atai Life Sciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Atai Life Sciences report Q1 2026 earnings?
- Atai Life Sciences (ATAI) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Atai Life Sciences 's Q1 2026 revenue and EPS?
- Atai Life Sciences reported revenue of $954.0K and eps of $-0.08 for Q1 2026.
- Did Atai Life Sciences beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $217.1K by $736.9K. EPS beat the consensus estimate of $-0.11 by $0.03.
- How did Atai Life Sciences 's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 38.6% from $1.6M a year earlier and eps grew 46.7% from $-0.15.